News report 📈 Stocks 🌍 Spain ISIN ES0105777017

Puig Acquires Full Control of Isdin in 1.2 Billion Euro Deal

Puig secures full ownership of Isdin for 1.2 billion euros, bolstering its strategic position in the high-growth dermocosmetics market while maintaining a disciplined debt profile.

🕐 1 min read

1 assets impacted. Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: PUIG ↑ 6/10 (62% confidence).

📊 Affected Assets (1)

PUIG
Bullish 🤖 62%
📆 Mid-term 🌍 ES · Explicit

Puig will gain full control of Isdin, a strategic dermocosmetics brand, with financing that maintains net debt/EBITDA below 2.0x, supporting long-term growth in skin care.

🎯 Key Takeaways

  • Puig will pay 900 million euros in cash at closing in Q1 2027, with a 300 million euro deferred payment due in 2029.
  • The acquisition aligns with Puig's strategic priority to expand its footprint in the intersection of science and beauty.
  • Puig confirms its net debt-to-EBITDA ratio will remain under 2.0x following the transaction.

📝 Executive Summary

Puig has agreed to acquire the remaining 50 percent stake in dermocosmetics brand Isdin from Corporación Químico-Farmacéutica Esteve for 1.2 billion euros. The transaction, expected to close in early 2027, will be funded through cash and debt, with Puig maintaining a net debt-to-EBITDA ratio below 2.0x to support long-term growth in the skin care sector.

❓ FAQ

How will the acquisition of Isdin impact Puig's financial leverage?

Puig expects its net debt-to-adjusted EBITDA ratio to remain below 2.0-times, consistent with its existing financial guidance.